Showing results (371-380 of 406) with videos related to

Sort By:
Pageof 41
Diagnostic Microbiology and Infectious Disease|August 28, 2012
Phaeoacremonium parasiticum invasive infections and airway colonization characterized by agar block smear and ITS and β-tubulin gene sequencingKelvin K W To, Susanna K P Lau, Alan K L Wu, et al.
European Journal of Heart Failure|June 10, 2017
Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fractionLena Bosch, Carolyn S P Lam, Lingli Gong, et al.
Clinical Cardiology|June 21, 2020
Ethnic differences in quality of life and its association with survival in patients with heart failureGillian Stein, Tiew-Hwa K Teng, Wan T Tay, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 15, 2024
End-of-life practices in Hong Kong intensive care units: results from the Ethicus-2 studyG M Joynt, S K H Ling, L L Chang, et al.
Heart (British Cardiac Society)|July 13, 2016
Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failureCrystel M Gijsberts, Lina Benson, Ulf Dahlström, et al.
The Science of the Total Environment|September 27, 2016
Tropospheric volatile organic compounds in ChinaH Guo, Z H Ling, H R Cheng, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factorsAnne W M Lee, W T Ng, W M Hung, et al.
European Journal of Heart Failure|August 8, 2012
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fractionRajalakshmi Santhanakrishnan, Jenny P C Chong, Tze P Ng, et al.
European Journal of Heart Failure|August 30, 2017
The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fractionAisha Gohar, Jenny P C Chong, Oi Wah Liew, et al.
Endocrinology|January 17, 2009
Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoproteinJitske de Vries-van der Weij, Willeke de Haan, Lihui Hu, et al.
Pageof 41